Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
99.13
+0.13 (0.13%)
At close: Mar 17, 2026, 4:00 PM EDT
99.80
+0.67 (0.68%)
After-hours: Mar 17, 2026, 7:38 PM EDT
Revolution Medicines Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
883
Market Cap
19.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 11.58M | -23.80M | -67.27% |
| Dec 31, 2022 | 35.38M | 5.99M | 20.38% |
| Dec 31, 2021 | 29.39M | -13.59M | -31.62% |
| Dec 31, 2020 | 42.98M | -7.06M | -14.10% |
| Dec 31, 2019 | 50.04M | 29.88M | 148.16% |
| Dec 31, 2018 | 20.17M | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 5.34B |
| Incyte | 5.14B |
| Genmab | 3.72B |
| BioNTech SE | 3.37B |
| Royalty Pharma | 2.38B |
| Moderna | 1.94B |
| Ascendis Pharma | 845.52M |
| Insmed | 606.42M |
RVMD News
- 2 hours ago - Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 1 day ago - Touchstone Mid Cap Growth Fund Q4 2025 Portfolio Review - Seeking Alpha
- 6 days ago - Harbor Health Care ETF Q4 2025 Portfolio Review - Seeking Alpha
- 14 days ago - Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 19 days ago - Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 21 days ago - Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 27 days ago - Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026 - GlobeNewsWire